Cloud for AI/ML & Modern Data Science Header Image

 

Cloud for AI/ML & Modern Data Science
AI/ML・モダンデータサイエンス向けクラウド

Design Agile, Scalable, Cost-Optimized Cloud Infrastructure
アジャイル、スケーラブル、コスト最適化されたクラウドインフラの設計

2025年4月2日〜4日 米国東部標準時(EDT)

クラウドテクノロジーの採用と展開は、デジタルトランスフォーメーションに不可欠です。イノベーションの推進、AI/ML機能の実現、最新のデータサイエンスのサポートには膨大な量のデータが必要なため、クラウドソリューションは不可欠です。ただし、数ある選択肢の中から自社に最適なものを見つけるのは容易ではありません。「AI/ML・モダンデータサイエンス向けクラウド」トラックでは、洞察力に富んだケーススタディとベストプラクティスを通じて、R&Dを推進し、コラボレーションとイノベーションを促進し、製薬R&Dを形成する技術の進歩に対応するのに必要な柔軟性を維持するために、理想的なクラウドまたはハイブリッドインフラとアプリケーションを選択するためのガイダンスを提供します。

4月2日(水)

Registration Open8:00 am

Recommended Pre-Conference Workshops and Symposia*9:00 am

On Wednesday, April 2, 2025, Cambridge Healthtech Institute is pleased to offer five pre-conference Workshops scheduled across two time slots (9:00 am–12:00 pm and 1:15–4:15 pm) and three Symposia from 9:00 am–4:20 pm. All are designed to be instructional, interactive, and provide in-depth information on a specific topic. They allow for one-on-one interaction and provide a great way to explain more technical aspects that would otherwise not be covered during the main conference tracks that take place Thursday–Friday.

*Separate registration required. See details on the Symposia here and details on the Workshops here.

4:40 pm

Organizer's Remarks

Cindy Crowninshield, Executive Event Director, Cambridge Healthtech Institute

4:45 pm Talk Title to be Announced

Speaker to be Announced, CLOVERTEX

4:55 pm PLENARY KEYNOTE PRESENTATION:

From Bytes to Breakthroughs: Generative AI Driving the Future of Life Sciences and Healthcare

Sofia Guerra, Vice President, Bessemer Venture Partners

Subha Madhaven, Vice President and Head, AI/ML, Quantitative and Digital Sciences, Global Metrics and Data Management, Pfizer Inc.

Generative AI has the potential to transform life sciences and deliver unprecedented insights, automation, and efficiency. But is it? This keynote panel brings together leaders from biopharma, healthcare, and emerging tech who are leveraging AI to advance drug discovery, diagnostics, and patient care. Panelists will share their own case studies and real-world applications and discuss how they’ve tackled challenges—both technical and cultural. Look beyond the hype curve to see how this technology is really being used now and where the next opportunities lie.

Welcome Reception in the Exhibit Hall with Poster Viewing (Sponsorship Opportunity Available)6:10 pm

The Bio-IT Kickoff Reception is a reunion—reconnect with friends, explore cutting-edge research, and celebrate innovation! Enjoy poster presentations, networking, and vote for the Best of Show and Poster awards.

Close of Day7:25 pm

4月3日(木)

Registration Open7:00 am

8:00 am

Organizer's Remarks

Allison Proffitt, Editorial Director, Bio-IT World and Clinical Research News

8:05 am Talk Title to be Announced

Speaker to be Announced, Snowflake Computing Inc

AI-POWERED PLATFORMS IN DRUG DISCOVERY: TACKLING ANTIBIOTIC RESISTANCE AND AGING THERAPEUTICS
創薬におけるAI活用のプラットフォーム:抗生剤耐性と老化治療への取り組み

8:15 am PLENARY KEYNOTE PRESENTATION:

Deep Learning for Antibiotic Discovery

James J. Collins, PhD, Termeer Professor, Medical Engineering & Science, Massachusetts Institute of Technology

In this presentation, we highlight the Antibiotics-AI Project, which is a multi-disciplinary, innovative research program that is leveraging MIT's strengths in artificial intelligence, bioengineering, and the life sciences to discover and design novel classes of antibiotics. The Antibiotics-AI Project is focused on developing, integrating, and implementing deep learning models and chemogenomic screening approaches: (1) to predict novel antibiotics from expansive chemical libraries with diverse properties, (2) to design de novo novel antibiotics based on learned structural and functional properties of existing and newly discovered antibiotics, and (3) to identify, using explainable deep learning models, the chemical structures and molecular mechanisms underlying the newly discovered and/or designed antibiotics. With these deep learning approaches, we are utilizing multi-scale computation to embrace and harness the complexity of biology and chemistry, so as to discover, design, and develop new classes of antibiotics, up through preclinical studies. Our platform has been designed so that it can be utilized and applied in a rapid fashion to emerging and re-emerging bacterial pathogens, including multidrug-resistant (MDR) bacteria and extensively drug-resistant (XDR) bacteria.

8:45 am PLENARY KEYNOTE PRESENTATION:

Generative AI, Aging Research and Robotics as a Platform for Drug Discovery: From Hype to Clinical Efficacy

Alex Zhavoronkov, PhD, Founder & CEO, Insilico Medicine

9:15 amSession Q&A

Coffee Break in the Exhibit Hall with Poster Viewing (Sponsorship Opportunity Available)9:30 am

Start your morning with coffee, connections, and cutting-edge research! Enjoy poster presentations, network in the Exhibit Hall, vote for awards, and a chance at a fabulous raffle prize!

Organizer's Welcome Remarks10:15 am

SETTING UP AND SCALING AGILE DATA AND ANALYTICS ECOSYSTEMS
アジャイルなデータ・アナリティクスエコシステムの設定とスケーリング

Chairperson's Remarks (Sponsorship Opportunity Available)10:20 am

10:25 am

Scaling AI/ML in Biotech: A Survey of Cloud Trends and Innovations

Drew Dresser, Director, Cloud Engineering, Flagship Pioneering

This presentation surveys how Flagship Pioneering’s portfolio companies use cloud technologies to scale AI/ML models. We’ll examine architecture patterns, strategies, and lessons learned, showcasing methods for scaling compute and pipelines. Additionally, the talk will highlight emerging trends in cloud and AI/ML, offering insights into how these innovations are shaping the future of biotech research. Attendees will gain practical strategies for optimizing cloud environments to drive AI/ML growth in biotech.

10:55 am

Cloud Genetics: A Blueprint for Precision Medicines

Gregory Hinkle, PhD, Vice President, Research Informatics, Alnylam Pharmaceuticals, Inc.

This presentation will detail challenges and solutions in implementing large-scale human genetics to support sequence-based precision medicines like RNAi therapeutics. Key topics will include data management, cost effectiveness, and navigating ever more stringent data security standards. The talk will highlight innovative strategies and technologies that Alnylam put in place that paved the way for the development and delivery of novel RNAi therapeutics to patients in need. Human genetics is at the heart of drug discovery at Alnylam. Effective, large scale human genetics is a data management and computational challenge. The loss of trust and the growth of human genetics projects as data.

11:25 am

Flexible Architecture for Machine Learning for Genomics

Yohann Potier, PhD, Senior Director, Data Platform, Tessera Therapeutics, Inc.

Flexible Architecture for Machine Learning for Genomics: This talk will explore the architecture for developing, deploying, and scaling machine learning models in genomics. It will emphasize the importance of creating a flexible infrastructure that can accommodate a range of ML workloads for drug development. Key topics will cover optimizing model training, managing datasets, and efficiently utilizing compute resources to meet different workload demands while ensuring cost-effectiveness and scalability.

11:55 am Talk Title to be Announced

Speaker to be Announced, Seqera Labs SL

12:25 pm Talk Title to be Announced by Pinnacle Technology Partners Inc

Speaker to be Announced, Pinnacle Technology Partners Inc

Presentation to be Announced12:40 pm

Session Break and Transition to Lunch12:55 pm

Luncheon Presentation (Sponsorship Opportunity Available) or Enjoy Lunch on Your Own1:05 pm

Refreshment Break in the Exhibit Hall with Poster Viewing (Sponsorship Opportunity Available)1:35 pm

Bio-IT's hall is bigger than ever—one break won’t cut it! Enjoy dessert and coffee after lunch, explore booths and posters, vote for awards, and participate in our raffle for a chance to win a prize!

LEVERAGING CLOUD FOR FASTER, BETTER DATA MANAGEMENT AND ANALYTICS
クラウドを活用し、高速かつ優れたデータ管理とアナリティクスを実現

Chairperson's Remarks (Sponsorship Opportunity Available)2:25 pm

2:30 pm

Transforming Drug Discovery: Leveraging Secure, Federated Learning to Collaboratively Train AI Models on the Proprietary Molecular Data of Multiple Organizations

John Karanicolas, PhD, Professor, Molecular Therapeutics, Fox Chase Cancer Center

Robin Roehm, CEO & Co-Founder, Apheris

A major challenge in advancing AI algorithms for modern drug discovery is the limited availability of protein and ligand structures needed to train AI models. For the first time, leading biopharmaceutical companies enable collaborative training of AI models that predict the 3D structure of molecular complexes using their proprietary protein structure data. In our talk, we will introduce the AI Structural Biology Consortium and present initial results.

3:00 pm

Keeping Pace with the Speed of Science: Evolving Cloud Architectures for Scale and Cost in Life Sciences

Nick Whalen, Data Architecture, Standards and Flow, Novartis

From the design of embarrassingly parallel compute for High Content Image Analysis, to management of large clinical data sets, to emerging therapeutic modalities, the demand to design performant architectures at scale while not breaking the bank is an essential skill for any organization looking to leverage the benefits of cloud technologies. In this talk, we explore strategies and techniques to keep costs down while balancing demanding user requirements and tight budgets.

3:30 pm

State-of-the-Art Hybrid Cloud Solutions in Conjunction with an External Partner

David Herzig, Principal Scientist, Roche Pharma

In today's landscape, system architectures are frequently developed in partnership with external providers, with the software hosted in the cloud by the chosen vendor. Responsibilities for support, maintenance, and customization are often distributed among the user, the provider, and occasionally a third-party support service. Running a system in an external cloud environment presents both organizational and technical challenges. This presentation will explore how these challenges can be effectively addressed, using the example of an ELN software.

Presentation to be Announced (Sponsorship Opportunity Available)4:00 pm

Best of Show Awards Reception in the Exhibit Hall with Poster Viewing (Sponsorship Opportunity Available)4:30 pm

Unwind with colleagues at our lively reception! Explore posters, vote for the best, network with exhibitors, enjoy a drink, and try to win a raffle prize. Celebrate Best of Show winners!

Close of Day5:45 pm

4月4日(金)

Registration Open7:00 am

Quick Bytes & Networking Breakfast—Lifted Rooftop Restaurant & Bar (Sponsorship Opportunity Available)7:00 am

Start your morning with ‘Quick Bytes & Networking’! Enjoy a cozy restaurant-style setting, quick bites, and speed networking. Connect, converse, and energize your Bio-IT experience before the plenary keynote!

8:00 am

Organizer's Remarks

Cindy Crowninshield, Executive Event Director, Cambridge Healthtech Institute

8:05 am

Innovative Practices Awards: Excellence in Technological Innovation

Allison Proffitt, Editorial Director, Bio-IT World and Clinical Research News

The Innovative Practices Awards recognizes and celebrates technology innovation in the life sciences. Bio-IT World is currently accepting entries for the 2025 Innovative Practices Awards, a competition designed to recognize partnerships and projects pushing our industry forward. Winners will be announced in mid-March 2025, recognized during the Friday, April 4 Plenary Keynote Program, and scheduled to give a podium presentation about their project during the conference. For more details about the Awards and to submit an application, visit www.bioitworldexpo.com/innovativepractices.

8:20 am Talk Title to be Announced

Speaker to be Announced, Illumina

ADVANCING DRUG DISCOVERY AND HEALTHCARE THROUGH DATA-DRIVEN INNOVATION: FROM GENOMICS TO THERAPEUTICS
データドリブンのイノベーションによる創薬とヘルスケアの進歩:ゲノミクスから治療まで

8:30 am PLENARY KEYNOTE PRESENTATION:

Scaling Genomic Medicine: Transforming Newborn Screening through Informatics and Innovation

Robert C. Green, MD, MPH, Professor and Director of Genomes2People Research, Mass General Brigham, Broad Institute, Ariadne Labs and Harvard Medical School

The BabySeq Project has pioneered the integration of genomic sequencing into newborn and childhood screening, uncovering unexpected risk variants and transforming healthcare delivery. This keynote explores the groundbreaking progress in genomic medicine, featuring real-world stories of families impacted by these discoveries. Learn about the informatics challenges and innovative solutions required to scale genomic screening for national and global implementation, reshaping the future of precision medicine.

9:00 am PLENARY KEYNOTE PRESENTATION:

Unlocking the Power of Machine Learning and Data-at-Scale to Deliver with Speed the Best Therapeutic Candidates

Justin M. Scheer, PhD, Vice President In Silico Discovery & Head, Molecular Computational Team, Johnson & Johnson Innovative Medicine

The challenges of high costs, lengthy timelines, and significant attrition have prompted our industry to integrate AI/ML into all aspects of the business. This presentation highlights J&J's strategic investments in AI/ML technologies to enhance the drug discovery processes, including molecule design and optimization. By investing in these technologies with a modality agnostic approach, J&J aims to tackle the hardest targets in drug discovery, ultimately increasing the success rate of delivering better molecules faster.

9:30 amSession Q&A

Coffee Break in the Exhibit Hall with Poster Competition Winners Announced (Sponsorship Opportunity Available)9:45 am

Bio-IT is all about connections! Explore booths, award-winning posters, and network with clients, colleagues, and exhibitors. Grab coffee, build relationships, and stay for a chance to win a raffle prize!

Organizer's Remarks10:30 am

BENEFITS OF CLOUD IN BIOPHARMA: CASE STUDIES AND BEST PRACTICES
バイオファーマにおけるクラウドの利点:ケーススタディとベストプラクティス

Chairperson's Remarks (Sponsorship Opportunity Available)10:35 am

10:40 am

Using Durable Workflow Technology to Run Image Analysis in the Cloud

Matthew Gerring, MEng, Senior Manager, Computational Sciences, The Jackson Laboratory

In this talk, we will show how image analysis can be taken from research level software to high quality and production ready systems. Attendees will learn how Jackson Laboratory transitioned research-level software into production-ready systems for scalable and durable image analysis. This presentation will feature biological image data, offer insights into new paradigms for cloud-based analysis, and appeal to those interested in scaling analysis of any type using distributed programming and cloud technologies.

11:05 am

One Research Digital—Ecosystems of FAIR Data Lakes Enabling AI-Augmented Analysis, Modeling, and Reporting

Marcin von Grotthuss, PhD, Director, Data Integration and Analytics, Preclinical and Translational Sciences, Takeda Pharmaceutical Co., Ltd.

The collaborative efforts within Takeda, supported by external vendors, led to the development and prototyping of One Research Digital—an ecosystem comprised of FAIR data lakes. During the design phase, we adhered to the FAIR principles and utilized a data lake infrastructure with a flexible data storage schema as the system's cornerstone. These advancements enable us to enhance AI-augmented analysis, modeling, and reporting across preclinical and translational sciences.

11:25 am

Ultra-Large Virtual Screening is Enabled by Orchestrating Cloud-Based Computation

Rajarshi Guha, PhD, Senior Director, Data & Computational Sciences, Vertex Pharmaceuticals Inc.

Reaction-based virtual libraries have expanded our access to chemical spaces of billions of virtual molecules. Searching such spaces for molecules of interest can be performed in many ways, but they can usually be parallelized at multiple levels. We describe a virtual screening infrastructure that uses Nextflow to parallelize a Genetic Algorithm Virtual Screening (GAVS) coupled to computational chemistry primitives, such as shape matching and docking, using AWS Lambda. Finally, we present some benchmark results highlighting the efficiency and accuracy of the method, along with the performance gains achieved by virtue of cloud-based parallelization.

11:45 am

Building a Serverless Data Platform for Biotech Companies

Patrick O'Mara, Associate Director, Research Informatics, Photys Therapeutics

This presentation showcases the construction of a serverless data pipeline for biotech start-ups. Using Apache Airflow on Google Cloud Composer, it automates data transfers between Egnyte, CDD Vault, and BigQuery. Highlighting CDD Vault's robust API and data model, the talk demonstrates how this solution enhances data management, accelerates insights, and supports innovation, offering a scalable and cost-efficient approach for biotech organizations.

Presentation to be Announced (Sponsorship Opportunity Available)12:10 pm

Session Break and Transition to Lunch1:10 pm

Luncheon Presentation (Sponsorship Opportunity Available) or Enjoy Lunch on Your Own1:20 pm

Refreshment Break in the Exhibit Hall with Last Chance for Poster Viewing (Sponsorship Opportunity Available)1:50 pm

Feeling tired? Recharge during the final Networking Exhibit Hall break! Visit booths, explore posters, connect with peers, and turn in your Game Cards for a chance to win a raffle prize.

Chairperson's Remarks (Sponsorship Opportunity Available)2:30 pm

TRENDS FROM THE TRENCHES: BRIDGING TRADITIONAL INSIGHTS WITH INNOVATIVE ADVANCEMENTS
現場のトレンド:従来の見識と革新的な進歩の橋渡し

2:35 pm

Transforming Big Data into Actionable Insights: Leveraging the Sequence Read Archive (SRA) for Life Sciences and Public Health

J. Rodney Brister, PhD, Acting Program Head, Sequence Read Archive, NCBI, NLM, NIH

As the world's largest publicly available repository of raw sequence data, the Sequence Read Archive (SRA) plays a pivotal role in advancing public health and life sciences research. This presentation highlights state-of-the-art tools and strategies for managing and analyzing the SRA’s massive datasets, showcasing its impact on infectious disease surveillance, genomic epidemiology, and precision medicine. Discover how innovative informatics solutions are transforming raw data into actionable insights for global health challenges.

3:05 pm

Refactoring Research Systems with AI: Modernizing Code for Life Sciences Innovation

Cindy Crowninshield, Executive Event Director, Cambridge Healthtech Institute; Additional Speakers to be Confirmed

With AI taking center stage in coding, research teams are leveraging AI-enabled IDEs to refactor legacy systems into modern, efficient languages. This talk presents a balanced view of generative AI-supported coding, cutting through the hype to focus on real-world applications. Discover practical strategies and examples of how AI is transforming outdated research systems into scalable, maintainable, and future-ready platforms for life sciences.

3:35 pm

Trends from the Trenches

Ari E. Berman, PhD, CEO, BioTeam, Inc.

Since 2010, “Trends from the Trenches” has been a cornerstone of the Bio-IT program, delivering candid and occasionally blunt assessments of the most impactful and overhyped IT technologies in life sciences. This talk will provide a deep dive into computing, storage, cloud, data science, machine learning, and more, with a focus on supporting data-intensive science. Looking ahead, this talk will share forward-thinking predictions about emerging technologies and trends poised to shape the future of life sciences innovation, offering actionable insights for navigating the next wave of IT evolution.

Close of Conference4:05 pm

* 不測の事態により、事前の予告なしにプログラムが変更される場合があります。

Choose your language
Traditional Chinese
Simplified Chinese
Korean
English


会議の詳細はこちらをご参照ください